CompletedPhase 4

Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children

Canada80 participantsStarted 2006-05

Plain-language summary

The purpose of this study is to investigate the use of a new vapocoolant spray, Pain Ease, to reduce intravenous (IV) insertion pain in school-aged children receiving treatment in the Emergency Department.

Who can participate

Age range6 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 6-12 years old * Require an IV inserted in less than 30 minutes Exclusion Criteria: * Allergy to vapocoolant sprays * Vascular impairment * Diabetes mellitus * Developmental delay/inability to understand pain scale * Received analgesia in last 24 hours * Triaged as resuscitation

What they're measuring

pain score

Timeframe: at injection (< 1 minute)

Trial details

NCT IDNCT00130650

SponsorChildren's Hospital of Eastern Ontario

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-09

View on ClinicalTrials.gov More Pain trials